Chido-Amajuoyi Onyema G, Osaghae Ikponmwosa, Onyeaka Henry K, Shete Sanjay
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Internal Medicine, Texas A&M School of Medicine/Christus Health, Longview, TX, USA.
Vaccine X. 2024 Mar 13;18:100471. doi: 10.1016/j.jvacx.2024.100471. eCollection 2024 Jun.
Healthcare providers (HCPs) recommendations for HPV vaccination plays a critical role in increasing vaccination uptake. This study assesses the prevalence of reported barriers to HPV vaccination assessment and recommendation among HCPs in Texas.
Study data were obtained from a population-based survey of HCPs currently practicing in Texas. Participants were asked about their HPV vaccination assessment and recommendation practices and the reasons for not assessing or recommending the vaccine. Barriers were stratified by HCP characteristics including age, sex, race/ethnicity, location of practice, provider type, and type of facility.
Among the 826 HCPs included in this study, 47.3 % never, 49.6 % sometimes, and 3.0 % often/always assessed a patient's HPV vaccination status. Similarly, 36.0 % never, 36.2 % sometimes, and 27.9 % often/always recommended HPV vaccination. The most frequently reported barriers to assessment and recommendation of HPV vaccination were time constraints (22.9 %), delegating the task to others (15.0 %), lack of effective tools and information to give patients (12.0 %), and requiring additional training (9.2 %). HCPs who were female, less than 35 years old, non-Hispanic black, and nonphysician HCPs (Physician Assistant, Nurse Practitioner) most frequently reported lacking effective tools and information and a need for additional training.
The assessment and recommendation for HPV vaccination among HCPs in Texas is suboptimal. Barriers reported varied based on the provider's characteristics. Addressing these barriers, such as by providing more effective tools and information and offering additional training to HCPs, could potentially increase HPV vaccination rates in Texas. The findings also suggest that interventions should be tailored to specific demographic groups.
医疗服务提供者（HCPs）对人乳头瘤病毒（HPV）疫苗接种的建议对提高疫苗接种率起着关键作用。本研究评估了得克萨斯州医疗服务提供者中报告的HPV疫苗接种评估和建议障碍的普遍性。
研究数据来自对目前在得克萨斯州执业的医疗服务提供者进行的一项基于人群的调查。参与者被问及他们的HPV疫苗接种评估和建议做法以及不进行评估或建议接种疫苗的原因。障碍按医疗服务提供者的特征进行分层，包括年龄、性别、种族/民族、执业地点、提供者类型和机构类型。
在本研究纳入的826名医疗服务提供者中，47.3%的人从未、49.6%的人有时、3.0%的人经常/总是评估患者的HPV疫苗接种状况。同样，36.0%的人从未、36.2%的人有时、27.9%的人经常/总是建议接种HPV疫苗。报告的HPV疫苗接种评估和建议的最常见障碍是时间限制（22.9%）、将任务委托给他人（15.0%）、缺乏给患者的有效工具和信息（12.0%）以及需要额外培训（9.2%）。女性、年龄小于35岁、非西班牙裔黑人以及非医生医疗服务提供者（医师助理、执业护士）最常报告缺乏有效工具和信息以及需要额外培训。
得克萨斯州医疗服务提供者对HPV疫苗接种的评估和建议并不理想。报告的障碍因提供者的特征而异。解决这些障碍，例如提供更有效的工具和信息以及为医疗服务提供者提供额外培训，可能会提高得克萨斯州的HPV疫苗接种率。研究结果还表明，干预措施应针对特定人群量身定制。
